- Home
- CXM vs APGE Comparison
CXM vs APGE Comparison
Compare CXM & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXM
- APGE
- Stock Information
- Founded
- CXM 2009
- APGE 2022
- Country
- CXM United States
- APGE United States
- Employees
- CXM N/A
- APGE N/A
- Industry
- CXM Computer Software: Prepackaged Software
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CXM Technology
- APGE Health Care
- Exchange
- CXM Nasdaq
- APGE Nasdaq
- Market Cap
- CXM 2.1B
- APGE 2.4B
- IPO Year
- CXM 2021
- APGE 2023
- Fundamental
- Price
- CXM $7.79
- APGE $53.48
- Analyst Decision
- CXM Hold
- APGE Strong Buy
- Analyst Count
- CXM 12
- APGE 8
- Target Price
- CXM $9.92
- APGE $94.63
- AVG Volume (30 Days)
- CXM 1.3M
- APGE 896.1K
- Earning Date
- CXM 12-03-2025
- APGE 11-11-2025
- Dividend Yield
- CXM N/A
- APGE N/A
- EPS Growth
- CXM 163.85
- APGE N/A
- EPS
- CXM 0.45
- APGE N/A
- Revenue
- CXM $820,768,000.00
- APGE N/A
- Revenue This Year
- CXM $6.11
- APGE N/A
- Revenue Next Year
- CXM $5.38
- APGE N/A
- P/E Ratio
- CXM $17.30
- APGE N/A
- Revenue Growth
- CXM 6.08
- APGE N/A
- 52 Week Low
- CXM $6.75
- APGE $26.20
- 52 Week High
- CXM $9.69
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- CXM 50.67
- APGE 66.20
- Support Level
- CXM $7.51
- APGE $51.80
- Resistance Level
- CXM $7.91
- APGE $57.34
- Average True Range (ATR)
- CXM 0.18
- APGE 3.41
- MACD
- CXM 0.05
- APGE 0.15
- Stochastic Oscillator
- CXM 78.43
- APGE 79.84
About CXM Sprinklr Inc.
Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.